The global air conditioning market size reached $124.9 billion in 2025 and is projected to expand to $175.5 billion by 2035, growing at a CAGR of 3.5% during the forecast period (2026–2035). Market growth is supported by urbanization, rising building construction, and efficiency-focused cooling regulations.

RF-over-Fiber (RFoF) market was valued at $460.5 million in 2025 and is projected to reach $900.4 million by 2035, growing at a CAGR of 7.0% during the forecast period (2026–2035). RFoF is increasingly being adopted in defense and aerospace sectors as it transmits high-frequency signals over long distances with low loss and strong immunity to electromagnetic interference. This capability makes RFoF particularly suitable for radar systems, satellite communications, electronic warfare, and unmanned aerial platforms, where maintaining signal integrity and minimizing latency is critical. The technology also supports wide bandwidths and flexible deployment, enabling secure and reliable communication in both fixed and mobile applications, including harsh operational environments.

Polypropylene market was valued at $106.5 billion in 2025 and is projected to reach $171.2 billion by 2035, growing at a CAGR of 4.9% during the forecast period (2026–2035). Artificial intelligence and digitalization are becoming increasingly relevant in the global polypropylene market as producers confront tightening margins, volatile feedstock costs, and growing competitive pressure from new capacity additions. Propylene prices’ close link to crude oil and natural-gas fluctuations creates persistent cost uncertainty for manufacturers, and oversupply in Asia along with logistical disruptions further pressures profitability. AI-driven optimization offers a structured response by converting real-time market, sensor, and historical plant data into operational adjustments that reduce raw-material consumption, energy use, and transition losses. These technologies support more accurate forecasting of propylene needs, stabilize reactor performance, and minimize off-spec volumes during specialty-grade changes. 

Anti-jamming system market was valued at $6.8 billion in 2025 and is projected to reach $15.9 billion by 2035, growing at a CAGR of 8.9% during the forecast period (2026–2035). The global anti-jamming system market is experiencing rapid growth as governments, aviation authorities, and industry stakeholders prioritize the protection of critical navigation systems against rising threats such as GNSS jamming and spoofing. The increasing reliance on satellite-based navigation in aviation, transportation, and defence has intensified the demand for advanced solutions that integrate adaptive digital processing, multi-antenna technologies, and machine learning to provide secure and uninterrupted positioning, navigation, and timing (PNT). For instance, in June 2025, European Space Agency (ESA) and Leonardo have initiated a joint NAVISP project to develop Machine Learning-powered smart antennas designed to block jamming and unwanted satellite signals, enhancing GNSS resilience.

European diabetes care drugs market was valued at $29.3 billion in 2025 and is projected to reach $56.7 billion by 2035, growing at a CAGR of 6.9% during the forecast period (2026–2035). The Europe diabetes drug market is witnessing sustained expansion, primarily driven by the increasing prevalence of diabetes across the region. According to the International Diabetes Federation, diabetes prevalence in Europe is estimated at 9.8%, representing approximately 66 million diagnosed cases. This figure is projected to rise by nearly 10% by 2050, indicating a growing disease burden. Europe accounts for the highest number of type 1 diabetes cases, estimated at 2.7 million. From this total, nearly 15% are reported among individuals below 20 years of age, amounting to around 419,000 cases. The rising incidence of both type 1 and type 2 diabetes continues to accelerate demand for effective drug therapies. In 2024, diabetes-related healthcare expenditure in the region was estimated at USD 193 billion. This expenditure represented nearly 19% of total global diabetes spending. Additionally, Europe ranks second in terms of average cost per diabetes case, estimated at USD 2,951. These factors collectively highlight the strong growth potential of the diabetes drug market in Europe.

Clinical laboratory services market was valued at $169.8 billion in 2025 and is projected to reach $305.0 billion by 2035, growing at a CAGR of 6.1% during the forecast period (2026-2035). The clinical laboratory services market is witnessing strong momentum driven by the growing digitalization of laboratory operations. Laboratories are increasingly adopting integrated suites of central laboratory solutions, including laboratory information systems, automation platforms, and data analytics tools, to enhance operational efficiency and diagnostic accuracy. Digital tools are streamlining sample management, test workflows, and result reporting while enabling real-time data connectivity with healthcare providers. For instance, in June 2024, Labcorp announced the launch of Labcorp Global Trial Connect, a new suite of central laboratory solutions designed to accelerate clinical trials by improving workflows at investigator sites. The platform integrates digital, data, and operational tools to streamline study startup, patient recruitment, sample tracking, and data collection. Global Trial Connect aims to enhance the patient and investigator experience while helping biopharma sponsors bring therapies to market faster.

Global water-soluble polymers market size reached $34.20 billion in 2025 and is projected to expand to $49.47 billion by 2035, growing at a CAGR of 3.9% during the forecast period (2026–2035). Market growth is supported by increasing use in water treatment, pharmaceuticals, and food processing applications.

Facade market size reached $320 billion in 2024 and is projected to expand to $580 billion by 2035, growing at a CAGR of 5.6% during the forecast period from 2025 to 2035. Market growth is supported by increasing construction activity, rising urbanization, and growing emphasis on energy-efficient and sustainable building envelopes across commercial, residential, and industrial sectors.

Western Europe e-commerce logistics market was valued at $45.3 billion in 2025 and is projected to reach $120.8 billion by 2035, growing at a CAGR of 10.3% during the forecast period (2026–2035). Rising online retail penetration across Western Europe is a direct and foundational driver of expansion in the Western Europe e-commerce logistics market, as increased digital purchasing translates into higher parcel volumes and elevated demand for efficient delivery networks. According to Eurostat data, 77% of internet users in the EU reported buying goods or services online in 2024, up significantly from earlier in the decade, demonstrating deep consumer adoption of e-commerce platforms across Western European countries. This widespread online shopping behavior has expanded the number of parcels moving through logistics networks and intensified demand for last-mile delivery services, warehousing, and supply chain orchestration.

Global ostomy drainage bags market was valued at $4,869.0 million in 2025 and is expected to reach $7,068.6 million by 2035, expanding at a CAGR of 3.9% over the forecast period from 2026 to 2035. The rising global burden of colorectal cancer is a key driver supporting the growth of the ostomy drainage bags market. Colorectal cancer is the third most common cancer worldwide, accounting for approximately 10% of all cancer cases, and ranks as the second leading cause of cancer-related deaths globally. In 2020, health authorities reported over 1.9 million new colorectal cancer cases and more than 930,000 related deaths globally. The disease predominantly affects individuals aged 50 years and above, increasing the likelihood of surgical interventions such as colostomy and ileostomy procedures, which directly drive demand for ostomy drainage bags across hospital and home care settings